Announced Thu, 2 Jul · 18:47 IST
Board approves preferential issue of 24.10 lakh shares to non-promoters
Board & Shareholder Meetings View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Asston Pharmaceuticals board approved issuing up to 24,10,431 equity shares at Rs 115 each (face value Rs 10, premium Rs 105) to non-promoter investors on a preferential basis, raising up to Rs 27.72 crore. An EGM is scheduled on July 31, 2026 via video conferencing to seek shareholder approval.
Likely market impact
Dilution risk for existing shareholders; outcome depends on how the growth capital raised is used.